Literature DB >> 31764884

AUTOIMMUNE RETINOPATHY MIMICKING HERITABLE RETINAL DEGENERATION IN A PATIENT WITH COMMON VARIABLE IMMUNE DEFICIENCY.

Luke A Wiley1,2, Elaine M Binkley1,2, Adam P DeLuca1,2, Grefachew Workalemahu1,2, Nicole J Tatro1,2, Meagan A Luse1,2, Elizabeth L Kennedy1,2, James C Folk2, Todd E Scheetz1,2, Zuhair K Ballas3, Budd A Tucker1,2, Robert F Mullins1,2, Ian C Han1,2, Edwin M Stone1,2.   

Abstract

PURPOSE: 1) To describe a case of autoimmune retinopathy mimicking heritable photoreceptor degeneration in a patient with common variable immune deficiency and 2) to investigate the humoral and cell-mediated branches of the immune system in this patient to better understand the mechanism of immune-mediated photoreceptor damage in this disease.
METHODS: Retrospective chart review with evaluation of multimodal imaging, genotype analysis, and investigation of circulating autoantibodies and T-cell response to retinal antigens.
RESULTS: A 40-year-old woman with bilateral, progressive vision loss was referred for evaluation of a possible inherited retinal degeneration. She was found to have asymmetric peripheral visual field constriction, cystoid macular edema, vitreous cells, and bone spicule-like pigmentary changes in both eyes. An extensive workup for underlying infectious or inflammatory causes was unrevealing, and molecular analysis for heritable retinal degeneration failed to identify a plausible disease-causing genotype. Screening for antiretinal antibodies showed the presence of multiple antiretinal antibodies, consistent with a diagnosis of autoimmune retinopathy. Immunologic workup demonstrated markedly decreased levels of serum IgA and IgG, consistent with common variable immune deficiency. T-cells isolated from the patient showed increased proliferation when stimulated with human retinal proteins, supporting a role for both cell- and humoral-mediated autoimmunity. Treatment with mycophenolate mofetil and intravenous immunoglobin therapy slowed the progression of disease and resulted in preservation of her central vision.
CONCLUSION: Autoimmune retinopathy can be seen in common variable immune deficiency and has clinical findings similar to heritable photoreceptor degeneration. Both the humoral and cellular immune responses are involved in the pathophysiology. Immune modulatory therapy has stabilized the disease course in this patient and may play an important role in the management of autoimmune retinopathy.

Entities:  

Mesh:

Year:  2022        PMID: 31764884      PMCID: PMC9211761          DOI: 10.1097/ICB.0000000000000941

Source DB:  PubMed          Journal:  Retin Cases Brief Rep        ISSN: 1935-1089


  10 in total

1.  Seroreactivity against aqueous-soluble and detergent-soluble retinal proteins in posterior uveitis.

Authors:  Audrey C Ko; Jason P Brinton; Vinit B Mahajan; Bridget Zimmerman; Gregory S Brinton; Edwin M Stone; James C Folk; Robert F Mullins
Journal:  Arch Ophthalmol       Date:  2011-04

2.  Preparation and evaluation of human choroid extracellular matrix scaffolds for the study of cell replacement strategies.

Authors:  Kathleen R Chirco; Kristan S Worthington; Miles J Flamme-Wiese; Megan J Riker; Joshua D Andrade; Beatrix M Ueberheide; Edwin M Stone; Budd A Tucker; Robert F Mullins
Journal:  Acta Biomater       Date:  2017-05-05       Impact factor: 8.947

3.  Anti-γ-enolase autoimmune retinopathy manifesting in early childhood.

Authors:  Audrey C Ko; Jasmine Hernández; Jason P Brinton; Elizabeth A Faidley; Sarah A Mugge; Marilyn B Mets; Randy H Kardon; James C Folk; Robert F Mullins; Edwin M Stone
Journal:  Arch Ophthalmol       Date:  2010-12

4.  Retinitis pigmentosa and hypogammaglobulinemia.

Authors:  John C Starr; George W Brasher; John Dominguez; Arundhati Rao
Journal:  South Med J       Date:  2006-09       Impact factor: 0.954

5.  Autoimmune Retinopathy: An Immunologic Cellular-Driven Disorder.

Authors:  John R Heckenlively; Steven K Lundy
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

6.  Ocular immune privilege.

Authors:  A W Taylor
Journal:  Eye (Lond)       Date:  2009-01-09       Impact factor: 3.775

7.  Consensus on the Diagnosis and Management of Nonparaneoplastic Autoimmune Retinopathy Using a Modified Delphi Approach.

Authors:  Austin R Fox; Lynn K Gordon; John R Heckenlively; Janet L Davis; Debra A Goldstein; Careen Y Lowder; Robert B Nussenblatt; Nicholas J Butler; Monica Dalal; Thiran Jayasundera; Wendy M Smith; Richard W Lee; Grazyna Adamus; Chi-Chao Chan; John J Hooks; Catherine W Morgans; Barbara Detrick; H Nida Sen
Journal:  Am J Ophthalmol       Date:  2016-05-20       Impact factor: 5.258

Review 8.  Autoimmune Retinopathy: Current Concepts and Practices (An American Ophthalmological Society Thesis).

Authors:  H Nida Sen; Landon Grange; Marib Akanda; Austin Fox
Journal:  Trans Am Ophthalmol Soc       Date:  2018-03-08

9.  Clinically Focused Molecular Investigation of 1000 Consecutive Families with Inherited Retinal Disease.

Authors:  Edwin M Stone; Jeaneen L Andorf; S Scott Whitmore; Adam P DeLuca; Joseph C Giacalone; Luan M Streb; Terry A Braun; Robert F Mullins; Todd E Scheetz; Val C Sheffield; Budd A Tucker
Journal:  Ophthalmology       Date:  2017-05-27       Impact factor: 12.079

Review 10.  Are Anti-Retinal Autoantibodies a Cause or a Consequence of Retinal Degeneration in Autoimmune Retinopathies?

Authors:  Grazyna Adamus
Journal:  Front Immunol       Date:  2018-04-16       Impact factor: 7.561

  10 in total
  1 in total

Review 1.  Patient derived stem cells for discovery and validation of novel pathogenic variants in inherited retinal disease.

Authors:  Nathaniel K Mullin; Andrew P Voigt; Jessica A Cooke; Laura R Bohrer; Erin R Burnight; Edwin M Stone; Robert F Mullins; Budd A Tucker
Journal:  Prog Retin Eye Res       Date:  2020-10-29       Impact factor: 21.198

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.